Release Date: 13/04/17 17:37 Summary: Renounceable Rights Issue Prospectus Price Sensitive: Yes Download Document 146.3KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%